1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe T Cell Therapy Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe T Cell Therapy Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Rising cancer incidence rates globally.
- 5.1.3 Increased funding for immunotherapy research.
- 5.1.4 Growing demand for personalized medicine.
5.2 Market Opportunities
- 5.2.1
- 5.2.2 Expansion into autoimmune disease treatments.
- 5.2.3 Advancements in genetic engineering technologies.
- 5.2.4 Collaborations with biotechnology firms.
5.3 Future Trends
- 5.3.1
- 5.3.2 Increased focus on CAR T-cell therapy.
- 5.3.3 Integration of AI in treatment development.
- 5.3.4 Shift towards combination therapies.
5.4 Impact of Drivers and Restraints
6. Europe T Cell Therapy Market Regional Analysis
6.1 Europe T Cell Therapy Market Overview
6.2 Europe T Cell Therapy Market Revenue 2020-2030 (US$ Million)
6.3 Europe T Cell Therapy Market Forecast Analysis
7. Europe T Cell Therapy Market Analysis – by Modality
7.1 Research
- 7.1.1 Overview
- 7.1.2 Research: Europe T Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Commercialized
- 7.2.1 Overview
- 7.2.2 Commercialized: Europe T Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe T Cell Therapy Market Analysis – by Therapy Type
8.1 CAR T-cell Therapy
- 8.1.1 Overview
- 8.1.2 CAR T-cell Therapy: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.2 T-cell Receptor-based
- 8.2.1 Overview
- 8.2.2 T-cell Receptor-based: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe T Cell Therapy Market Analysis – by Indication
9.1 Hematologic Malignancies
- 9.1.1 Overview
- 9.1.2 T-cell Receptor-based: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Solid Tumors
- 9.2.1 Overview
- 9.2.2 T-cell Receptor-based: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe T Cell Therapy Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe T Cell Therapy Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 Europe T Cell Therapy Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 UK: Europe T Cell Therapy Market Breakdown, by Modality
- 10.1.1.1.2 UK: Europe T Cell Therapy Market Breakdown, by Therapy Type
- 10.1.1.1.3 UK: Europe T Cell Therapy Market Breakdown, by Indication
- 10.1.1.2 Germany:
Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Germany: Europe T Cell Therapy Market Breakdown, by Modality
- 10.1.1.2.2 Germany: Europe T Cell Therapy Market Breakdown, by Therapy Type
- 10.1.1.2.3 Germany: Europe T Cell Therapy Market Breakdown, by Indication
- 10.1.1.3 France:
Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 France: Europe T Cell Therapy Market Breakdown, by Modality
- 10.1.1.3.2 France: Europe T Cell Therapy Market Breakdown, by Therapy Type
- 10.1.1.3.3 France: Europe T Cell Therapy Market Breakdown, by Indication
- 10.1.1.4 Russia:
Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Russia: Europe T Cell Therapy Market Breakdown, by Modality
- 10.1.1.4.2 Russia: Europe T Cell Therapy Market Breakdown, by Therapy Type
- 10.1.1.4.3 Russia: Europe T Cell Therapy Market Breakdown, by Indication
- 10.1.1.5 Italy:
Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Italy: Europe T Cell Therapy Market Breakdown, by Modality
- 10.1.1.5.2 Italy: Europe T Cell Therapy Market Breakdown, by Therapy Type
- 10.1.1.5.3 Italy: Europe T Cell Therapy Market Breakdown, by Indication
- 10.1.1.6 Rest of Europe:
Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe T Cell Therapy Market Breakdown, by Modality
- 10.1.1.6.2 Rest of Europe: Europe T Cell Therapy Market Breakdown, by Therapy Type
- 10.1.1.6.3 Rest of Europe: Europe T Cell Therapy Market Breakdown, by Indication
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe T Cell Therapy Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Bristol-Myers Squibb Co
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Gilead Sciences Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Immunocore Holdings Plc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Innovent Biologics Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Janssen Global Services LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Legend Biotech Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Novartis AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe T Cell Therapy Market
